211 related articles for article (PubMed ID: 11889904)
41. Specificity and isotype of Rh specific antibodies produced by human B-cell lines established from alloimmunized Rh negative women.
Pasha RP; Bahrami ZS; Niroomanesh S; Ramzi F; Razavi AR; Shokri F
Transfus Apher Sci; 2005 Oct; 33(2):119-27. PubMed ID: 16103012
[TBL] [Abstract][Full Text] [Related]
42. Immunologic basis and immunoprophylaxis of RhD induced hemolytic disease of the newborn (HDN).
Payam Khaja Pasha R; Shokri F
Iran J Immunol; 2008 Dec; 5(4):189-200. PubMed ID: 19098362
[TBL] [Abstract][Full Text] [Related]
43. Heterogeneity of IgG1 monoclonal anti-Rh(D): an investigation using ADCC and macrophage binding assays.
Armstrong SS; Wiener E; Garner SF; Urbaniak SJ; Contreras M
Br J Haematol; 1987 Jun; 66(2):257-62. PubMed ID: 3038161
[TBL] [Abstract][Full Text] [Related]
44. IgG-mediated immunosuppression is not dependent on erythrocyte clearance or immunological evasion: implications for the mechanism of action of anti-D in the prevention of haemolytic disease of the newborn?
Brinc D; Le-Tien H; Crow AR; Freedman J; Lazarus AH
Br J Haematol; 2007 Oct; 139(2):275-9. PubMed ID: 17897303
[TBL] [Abstract][Full Text] [Related]
45. Human monoclonal antibodies against the rhesus D antigen from women with severe Rh immunization submitted to high-dose intravenous immunoglobulin treatment.
del Aguila C; Guillén MV; de la Cámara C; Llopis R
Vox Sang; 1994; 66(1):55-60. PubMed ID: 8146984
[TBL] [Abstract][Full Text] [Related]
46. Some observations on D antigen expression of D-positive and 'weak D-positive' red cells as assessed by flow cytometry.
Nelson M; Barrow LA; Popp H; Gibson J
Vox Sang; 1995; 69(2):152-4. PubMed ID: 8585204
[No Abstract] [Full Text] [Related]
47. Differences between the activities of human monoclonal IgG1 and IgG3 subclasses of anti-D(Rh) antibody in their ability to mediate red cell-binding to macrophages.
Wiener E; Atwal A; Thompson KM; Melamed MD; Gorick B; Hughes-Jones NC
Immunology; 1987 Nov; 62(3):401-4. PubMed ID: 3117677
[TBL] [Abstract][Full Text] [Related]
48. The Yorkshire antenatal anti-D immunoglobulin trial in primigravidae.
Tovey LA; Townley A; Stevenson BJ; Taverner J
Lancet; 1983 Jul; 2(8344):244-6. PubMed ID: 6135077
[TBL] [Abstract][Full Text] [Related]
49. A major role of class I Fc gamma receptors in immunoglobulin G anti-D-mediated red blood cell destruction by fetal mononuclear phagocytes.
Wiener E; Mawas F; Dellow RA; Singh I; Rodeck CH
Obstet Gynecol; 1995 Aug; 86(2):157-62. PubMed ID: 7617343
[TBL] [Abstract][Full Text] [Related]
50. [Obtention of a heterohybridoma for production of type IgM monoclonal antibodies against the D antigen of the Rh system].
León-González G; Cruz C
Invest Clin; 2007 Mar; 48(1):57-67. PubMed ID: 17432544
[TBL] [Abstract][Full Text] [Related]
51. Mothers at risk of alloimmunization to the Rh (D) antigen and availability of gamma-globulin at the Mexican Institute of Social Security.
Zavala C; Salamanca F
Arch Med Res; 1996; 27(3):373-6. PubMed ID: 8854398
[TBL] [Abstract][Full Text] [Related]
52. [Prevention of fetomaternal rhesus-D allo-immunization. Practical aspects].
Cortey A; Brossard Y
J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S123-1S130. PubMed ID: 16495838
[TBL] [Abstract][Full Text] [Related]
53. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
Spasova K; Vŭlcheva B
Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168
[No Abstract] [Full Text] [Related]
54. [Social Welfare Board's recommendations for preventive treatment in the origin of Rh immunization].
Högman C; Nilsson BA
Jordemodern; 1987 Oct; 100(10):321-4. PubMed ID: 2826372
[No Abstract] [Full Text] [Related]
55. [Diagnostic and therapeutic use of human anti-D (Rho) monoclonal antibodies. Evaluation and perspectives].
Rouger P; Goossens D; Champomier F; Tsikas G; Liberge G; Leblanc J; Richard C; Bailleul C; Salmon C
Rev Fr Transfus Immunohematol; 1985 Dec; 28(6):671-9. PubMed ID: 3006210
[TBL] [Abstract][Full Text] [Related]
56. An anti-idiotopic antibody-based enzyme-linked immunosorbent assay for the quantification of the monoclonal anti-D BRAD-5.
Austin EB; Smith LC; Walker RY
Vox Sang; 2001 Apr; 80(3):179-83. PubMed ID: 11449958
[TBL] [Abstract][Full Text] [Related]
57. [Monoclonal antibodies to Rho(D)-antigen of the Rhesus system. Obtaining the EBV-transformed B-lymphoblastoid human cell lines secreting IgG-anti-D antibodies].
Deriugina EI; Olovnikova NI; Lemeneva LN; Belkina EV; Udalov GA; Chertkov IL
Gematol Transfuziol; 1991 Aug; 36(8):11-6. PubMed ID: 1661249
[TBL] [Abstract][Full Text] [Related]
58. Gm typing, IgG subclasses of anti-Rh(D) and severity of hemolytic disease of the newborn.
Alie-Daran SJ; Dugoujon JM; Fournie A
Vox Sang; 1992; 62(2):127-8. PubMed ID: 1519368
[No Abstract] [Full Text] [Related]
59. The clinical significance of anti-G in alloimmunized pregnant women.
Hadley A; Poole J; Poole G
Transfusion; 1997 Sep; 37(9):985. PubMed ID: 9308650
[No Abstract] [Full Text] [Related]
60. Reversal of Rh alloimmunization. Fact or fancy?
Bowman JM; Pollock JM
Vox Sang; 1984; 47(3):209-15. PubMed ID: 6087562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
